The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.
Lakatos PL, Lovasz BD, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Vegh Z, Mandel M, Horvath A, Szathmari M, Kiss LS, Lakatos L.
Lakatos PL, et al. Among authors: lakatos l.
J Crohns Colitis. 2013 Jun;7(5):385-91. doi: 10.1016/j.crohns.2012.06.011. Epub 2012 Jul 4.
J Crohns Colitis. 2013.
PMID: 22766526